Clinical Trial Update: Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the effects of glycyrrhetinic acid on serum potassium and insulin resistance in patients with end-stage renal disease; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Glycyrrhetinic acid (glycyrrhetinic acid)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED